According to a report published by Bloomberg on Thursday, Meta is preparing to introduce two new models of Ray-Ban smart glasses designed specifically for prescription wearers. The models, codenamed Scriber and Blazer, first appeared in Federal Communications Commission filings and are expected to reach consumers early next week. They do not represent new generation devices. They represent something potentially more important: distribution strategy.
Prescription eyewear accounts for about 69 percent of the $223 billion global eyewear market. Meta sold more than seven million Ray-Ban and Oakley AI frames in 2025, an impressive number for a product category that barely existed three years ago, but a rounding error against the roughly 1.5 billion people who wear corrective lenses worldwide. The new models are Meta’s clearest attempt yet to move smart glasses from consumer electronics to mainstream optical retail, where customers, margins and scale are significantly larger.
What are new models and what are not
The Scriber and Blazer are screenless AI glasses similar to the existing Ray-Ban Meta line: camera, microphone, speakers and Meta AI integration, but no screen. Blazer will be available in regular and large sizes; Scriber seems to be a one-size-fits-all proposition. Both include Wi-Fi 6 UNII-4 band support, an upgrade over current models, and will ship with charging cases.
The difference is important because Meta already sells a model equipped with a display. The Ray-Ban Meta Display, introduced at Connect 2025, includes a full-color head-up display, a 12-megapixel camera with 3x zoom, and pairs with a neural armband that reads muscle signals to navigate the interface. It costs $799. Orion, Meta’s fully augmented reality prototype with holographic displays, remains a research project with no consumer launch date.
Scriber and Blazer sit below both in the product hierarchy. Their goal isn’t to showcase Meta’s cutting-edge technology, but to put Meta AI into frames that people already have to buy. The idea behind the move is simple: if someone needs prescription lenses and is going to spend a few hundred dollars on an optician regardless, the incremental cost of making those lenses smart is significantly reduced. Mark Zuckerberg made the strategic rationale clear in his recent earnings call, noting that “billions of people wear glasses or contacts for vision correction” and “it’s hard to imagine a world in a few years where most of the glasses people wear are not AI glasses”.
Question from EssilorLuxottica
The prescription pivot also taps directly into the most complex relationships in Meta’s hardware business. EssilorLuxottica, the Franco-Italian conglomerate that owns Ray-Ban, Oakley, LensCrafters and Sunglass Hut, makes all of Meta’s smart glasses and controls the optical retail channel through which the new models will be sold. The partnership has produced results, but it has also created friction.
Bloomberg reported in February that the two companies were working through differences over pricing and strategy. EssilorLuxottica’s adjusted gross margin fell 2.6 percentage points to 60.9 percent in 2025, due in part to the higher component costs that smart glasses require compared to conventional frames. Meta wanted to offer Black Friday discounts in 2023; EssilorLuxottica, which has carefully guarded its luxury positions, rejected the idea. The tension is structural: Meta wants to maximize adoption and connect users to the AI ecosystem. EssilorLuxottica wants to protect margins on a product line that is eroding them.
Prescription models can reduce this tension. Prescription lenses have higher retail prices and fatter margins than non-prescription sunglasses. Lens coatings, custom grinding and matching appointments required by prescription orders generate additional revenue at every stage of the value chain. If smart glasses move into the prescription channel at scale, the economics improve Essilor Luxottica even as volumes increased for Meta. The companies are reportedly considering doubling their joint production target to 20 million units per year from an estimated capacity of 10 million units by the end of 2026.
Risks in the optical chair
Selling smart glasses through optical retail creates complications that consumer electronics channels do not. Opticians are trained to fit lenses, not to explain AI assistants, camera privacy settings or software updates. The customer experience at LensCrafters is fundamentally different from that at the Meta Store or the Apple Store, and the staff training, product support and returns required for a connected device are more complex than for a pair of Wayfarers.
There is also legal exposure. Solos Technology filed a patent infringement lawsuit against Meta and EssilorLuxottica in January 2026, alleging that the Ray-Ban Meta line infringed several patents covering key smartglass technologies and seeking “several billion dollars” in damages. The second patent front, on top of partnership tension and margin pressure, adds risk to a product line that Meta sees as the core of its wearable AI strategy.
The smart glasses market is growing rapidly, from an estimated $2.5 billion in 2025 to $14.4 billion by 2033, but almost all of that growth is speculative and depends on whether consumers opt for connected frames when regular glasses are cheaper, lighter and less portable. privacy concerns. That’s the meta bet AI functionalityin particular, the ability to ask questions without reaching for the phone, access real-time information and interact with digital services will be attractive enough to overcome these objections.
Scriber and Blazer are not products that will definitely test this bet. They’re the product that puts Meta’s artificial intelligence into the matching cases of opticians, into the faces of people already looking to buy new glasses, and into a distribution channel that reaches billions of potential customers. Technology is incremental. Not a strategic ambition.
